Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa… - Clinical infectious …, 2013 - academic.oup.com
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …
被引用次数：371 相关文章

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa… - … diseases: an official …, 2013 - pubmed.ncbi.nlm.nih.gov
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …
[PDF] archive.org

[PDF][PDF] Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review …

ME Falagas, GS Tansarli, K Ikawa… - Clinical Infectious …, 2013 - scholar.archive.org
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …

[引用][C] Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review …

ME Falagas, GS Tansarli, K Ikawa… - Clinical Infectious …, 2012 - cir.nii.ac.jp
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of
Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis | CiNii …

Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and …

ME Falagas, GS Tansarli, K Ikawa… - Clinical Infectious …, 2013 - search.ebscohost.com
The meta-analysis of mainly non-randomised studies suggests that continuous or extended
infusion of carbapenems and piperacillin/tazobactam was associated with lower mortality …

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa, KZ Vardakas - 2013 - cabidigitallibrary.org
We sought to study whether the better pharmacokinetic and pharmacodynamic (PK/PD)
properties of carbapenems and piperacillin/tazobactam, when the duration of infusion is …

[引用][C] Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review …

ME FALAGAS, GS TANSARLI, K IKAWA… - Clinical infectious …, 2013 - pascal-francis.inist.fr
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of
Carbapenems and Piperacillin/ Tazobactam: A Systematic Review and Meta-analysis CNRS …

Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta …

ME Falagas, GS Tansarli, K Ikawa… - … Infectious Diseases: an …, 2012 - europepmc.org
A comment on this article appears in" Reply to Soman et al and Frippiat et al." Clin Infect Dis.
2013 Jul; 57 (2): 325-7. A comment on this article appears in" Are prolonged/continuous …